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ABSTRACT 
NPC is a disease in which malignant cells are formed in the tissue of 
nasopharynx. It is a highly prevalent disease in Southern China and Southeast Asia 
including Malaysia. CGH is a molecular cytogenetic technique which is used to identify 
imbalanced genetic alterations in this malignancy. Twenty eight samples were obtained. 
Out of this; twelve tumors were extracted from twelve NPC biopsies while twelve 
references DNA was extracted from twelve normal controls peripheral blood. Tumor 
DNA and normal DNA was labeled by nick translation method with green and red 
fluorescent dyes. These were hybridized at metaphase chromosomes DNA and 
counterstained with DAPL Finally, the image was captured and analyzed. Chromosomal 
gains that were found in this study were 4q26, llql3-ql4, 9pl3, 8ql3-q22 and 10q22-
q26 while chromosomal losses were found at region 20p12 and 13q21-q31. We believe 
this study has provided the platform for further investigations to locate possible tumor-
suppressor genes and oncogenes in our NPC patients. 
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ABSTRACT 
Nasopharyngeal Carcinoma (NPC) is highly prevalent in Southern China and Southeast 
Asia. To unveil the molecular basis of this endemic disease, Comparative Genomic 
., · Hybridization (CGH) technique was used to identifY imbalanced genetic alterations in 
this malignancy. Chromosomal gains that were found in this study were 4q26 (20%) and 
11 q 13- q 14 (20% ), while chromosomal losses were 20p 12 ( 40"/o) and l3q21-q31 (20% ). -. 
============~=============----- --
) 
These preliminary results suggest that -ifiere may be aetivation of oncogene in the gaJil 
regions and suppression of tumor suppressor gene in the loss regions. 
Introduction 
Nasopharyngeal Carcinoma (NPC) is a common cancer in Southeast Asia and its 
prevalence is clearly affected by genetic background. More than 800/o of patients achieve 
long term survival, if they are treated in the early stages. However, majority are 
diagnosed at late stage which makes treatment less effective and difficult.• Unveiling the 
molecular basis of this cancer is important, in order to derive targets for novel therapeutic 
strategies and control of this disease: Investigations on susceptibility genes would be of 
interest. Some genetic changes such as allelic loss, chromosomal gains or losses and 
specific gene alterations were reported to occur frequently in NPC. However, little is 
known about specific gene(s) related to the genesis or progression ofNPC. Chromosomal 
imbalances identifiable through Comparative Genomic Hybridization (CGH) may shed 
some light on common genetic alterations that. may be of relevance to the onset and 
progression ofNPC. So, a study wa8 designed to identify the genetic imbalances in NPC 
employing CGH technique. This technique permits a rapid screening of genetic 
l!!!_bi!!l!ll~S tltroughout the entire tumor genome without the need ofprior knowledge of 
the genetic alteration to be investigated. Since its development, CGH has been applied to 
analyze genomic abnormalities in many types of solid tumours. Many previously 
unrecognized sites of recurrent genomic alterations which may harbor oncogenes or 
tumour suppressor genes have been detected by this approach, providing useful 
information on candidate chromosomal regions for further study. 
) 
-==========--~~- ~~ 
Materials and methods 
Patients with Nasopharyngeal Carcinoma (NPC), diagnosed clinically and 
histopathologically were enrolled into this study. Tumor DNA was extracted from NPC 
biopsies while reference DNA was extracted from normal controls peripheral blood. 
Then, tumor DNA and normal reference DNA were labeled by nick translation method 
with green and red fluorescent, respectively. Hybridization of red and green labeled DNA 
to metaphase spread was performed. DNA was counterstained with 4',6-diamidino-2-
phenylindole (DAPI). Finally, the image was captured and then analyzed by Cytovision 
software {Applied Imaging). 
Results and Discussion 
Among our study subjects, we observed that Malays were higher than Chinese and there 
were no Indian patients. All the' samples were Type I NPC which was Poorly 
Differentiated Carcinoma. The cases were all males. with age between 55 and 65 years 
old. We also found that pattern ofNPC in Kelantan population is in contrast with study 
that have been done by Nicholls et al in North American and Southern Chinese 
population. In North American population, 25% were type I, 12% were type II and 63% 
wete type UI. In SoutJtem Chinese papulation, only 2"/o were type l, 3%-type II and 
95% were type III. These finding may be due to the different population distribution in 
Kelantan. But larger sample size is needed to confirm this ~ult. 
Fipre 1: CGH profile of case 2. Fluorescent ratio profiles calculated are plotted alongside the 
chromosome ideogram. Red and green lines represent thresholds for chromosomal losses (0.75) and gains 
(1.25), respectively. 
In this preliminary analysis, we identified chromosomal gains at 4q26 (20%) and 11 q 13 
(200/o) while chromosomal losses were identified at 20p 12 ( 40%) and 13q22-q31 (200/o) 
· ~:.{Rel'efJigiireu 1). It is presumed that there may be activation of oncogene in the gain 
regions and suppression of tumor suppressor gene in the loss regions. All chromosomal 
imbalances that were detected in this study were consistent with other study except for 
20pl2. Areas of gain such as 3p, Sq 12p, 12q or loss such as 14p and 14q were reported 
to represent earlier and more fundamental chromosomal aberrations that occur early 
during NPC oncogenesis. In Chen et a!' s (1999) study, on 51 NPC tumours, (25 primary 
and 26 recurrent tumours) the most common copy number increases occurred on 
chromosome arms l2p (59"/o), lq· (47%), l7q (47%), llq (41%) and l2q (35%). 
Chromosomal gain at llq 13 was the most frequent gain found in the study done by Hui 
eta! (2005). Six oncogenes located at this region were MEN l, CCND l, FGF 3, EMS l, 
GARP, and PAK l genes. In their study, CCNDl gene found to be the most frequent 
oncogene that was over express. In contrast, we found only 20% of the samples to have 
llql3 gain. In our study, loss at 20pl2 was the most frequent alteration. This finding 
maybe due to the different histological pattern found in our patient population. All the 
patients were keratinizing squamous cell carcinoma (Type I) NPC which is poorly 
differentiated subtype. In Hui eta! stUdy, most of the samples were Type III. 
Conclusions 
This preliminary analysis has demonstrated that CGH is an effective method to survey 
the NPC genome for chromosomal regions of variant DNA sequence copy numbers. This 
Study has provided evidence for sites of several recurrent chromosomal abnormalilties 
including 4q26, llql3, 20pl2 and l3p22-q3l. Further studies are warranted to identify 
) 
regions most likely to contain genes of biological significance to NPC development and 
pwg;essioo. 
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. lJ)EN'fiFICATION OF GENETIC IMBALANCES OF . 
U\SOPiHA1ltll~GI!IAL CARCINOMA (NPC) BY COMPARATIVE 
EN()MJ:C HYBRIDIZATION (CGH): A PRELIMJNARY REPORT 
bt Che Hanua, 1Shamim Ahmed Khan, ~an Jaafar, "Fauziah Mohd ldris, 
~zahMohd Yussof, 5James Ashman, 'Zulklflee Salehuddin and 1ZilfalD Alwi 
{Jenome Centre, 2Department OfOtorinolaringology, :lnepartment Of Pathology, 
iirtlitentOfMicrobiology, School Of Medical Sciences, Health Campus, UniversitiSains 
Kubang Kerian, Kelantan, 5 Advanced Dental & Medical Institute (Clinical Centre), 
Sains Malaysia, Pulau Pinang, 6nepartment Of Otorinolaringology , Hospital Raja · 
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~tive Genomic Hybridization (CGH) is a molecular cytogenetic technique that was 
from in situ hybridization technique. This technique Wlis designed to compensate the 
present in conventional cytogenetic and Fluorescent In Situ Hybridization (FISH) 
dqMmdent on cell culture. CGH can also be performed on archival material and it 
prior knowledge of the genetic aberrations. This technique can be used to identify 
genetic alterations such as deletions, gains and amplifications. Patients with 
~rugeal Carci»o1llll (NPC), diagnosed clinically and histopathologically were enrolled 
Study. This Study was conducted to identify the pattern of genetic imbalances in NPC 
llhtvsia. Tumor DNA was extracted from NPC biopsies while reference DNA was 
from normal controls peripheral blood. Then, tumor DNA and normal reference 
labeled by nick translation method with green and red fluorescent dyes, 
li¢th•elv. Hybridization of red and green fluorescent labeled DNA to metaphase spread was 
DNA was counterstailied with 4',6-diamidino-2-phenylindole (DAPI). Finally, the 
captured and then analyzed. Chromosomal gains that were found in this Study were 
{20%)and 1lql3~ q14 (20".4). Chromosomal losses that were observed in this study were 
(40"io) and l3q21-q31 (20".4). This preliminary Study postulates that there may be 
· · in the gain regions and suppression of tumor suppressor gene in the loss 
i,omr.i:lurfimfin!!S may also, in future, provide a comprehensive prefile of-chromosomal 
showing losses and gain in NPC within the Malaysian population. 
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MALAYSIA (HUSM) 
Naill MN, 2Shaniinl A K, 3Hasnan J, 4Azriani A R 'Zilfalil B A 
Genom Center, 'Department of Otolaryngology, 'Department of Pathology, "Department 
;lonmumiloyMedicine, School of Medical Sciences, Universiti Sains Malaysia, Health Campus 
Kubang Kerian, Kelantan, Malaysia. 
•.iectiv<e: To evaluate the characteristic and trend of NPC in patients registered for 
roattnerlt at Hospital Universiti Sains Malaysia (HUSM) from January 1999 to 
~~nber 2007. 
and Method: 106 patients with confirmed NPC were reviewed at HUSM, 
!i~~~~ over the time period from January 1999 to December 2007. These patients 
.....,d'mm Kelantan, Terengganu, Pahang, Perak, Johor, Kedah and Sabah. The patients 
j!:l11dedin this study had histologically proven NPC according to the World Health 
~anisati<m (WHO) classification and the Thmor, Node, Metastasis (TNM) staging. 
observed great difference in time in trend and characteristic of NPC in the.· 
iepulattions. Their clinical records were reviewed and clinical data collected. 
b!sults: The trends of NPC patients in HUSM are not constant The number of patients 
a continuous rise and sudden drop. The Malay ethnic group showed highest 
!i!wmb<er that attended HUSM. There were twice as many males as females. The highest 
age was in year 2000 which is 54.5 years. Majority of patients (46.2%) were 
WHO type ill classification which ·is different from previoris study done in HUSM. 
on the TNM staging, 63.2% patients had reached stage IV. Most of the Kelantan 
:fiatients (63.2%) were from Kota Bharu district which is the main district in Kelantan. 
~setJSSiion and Conclusion: Our result indicates that majority of the NPC patients 
f.atltenfutg HUSM were Malays. Over all number of new cases of NPC reporting to 
;.mJS~I'l have significantly dropped from 2005-2007. The mean age for every year is 
1l)e>tw<een 40-55 years which is similar to many previous studies . 
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Abstract Parallel Seminar 
PS-02 
Screening of Malay Patients With Nasopharyngeal Carcinoma (NPC) 
Using Comparative Genomic Hybridization (CGH) Technique for 
Identification of Specific Genetic Alterations 
N$tr11Nai!i MN1 , SbamimAK2 , HasoanJ3, FauziahMr', Narazah MY5, JamesA5, Zulkitlee 
ff, Zubaidah Z7, Chin L P7, Nidzam M M r', Zilfalil B A1 
1HUlll81'1 Genom Center, 2Department of Otolaryngology, 3Department of Pathology 
"DepartmeJit ofMicrobiology, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan 
5 Advanced Dental & Medical Institute (Clinical Centre), Universiti Sains Malaysia, Pu1au Pinang 
1lepartment of Otorinolaringology, Hospital RJga Perempuan Zainab H, Kota Bbaru, Kelantan 
7Cancer Research Center, Institute Medical Research, Jalan Pahang, Kuala Lumpm. 'Department of 
ORL-HNS, Hospital Sultanah Nur Zahirah, 20400 Kuala Tereng;ganu, Terengganu. 
Nasopharyngeal Carcinoma (NPC) is one of the most common cancers in Malaysia. 
Various genetic alterations including gain and losses in the chromosome of patients with 
NPC were reported in other population. However the patterns of chromosome 
aberration in Malaysian NPC patients have not been reported before. Comparative 
Genomic Hybridization (CGH) is a molecular cytogenetic technique that allows a rapid 
survey for regions of DNA sequences gain and loses. Using this technique we examined 
8 samples with primary NPC tumors. The 8 samples were received from the hospitals at 
the north eastern region of Peninsular Malaysia. All patients were male and belong to 
Malay ethnic group. Based on WHO classification, 3 cases were classified type I NPC, 
2 cases type II while 3 cases were type m. CGH was performed to screen the genetic 
alterations in NPC patients. We found chromosomal gains at region 4q26 (25%) and 
llq13-q14 (25%) while chromosomal losses at region 20p12 (25%) and 13q21-q31 
(25%) on patients 2. No chromosomes aberrations were found in other 7 samples. 
Contamination of tumor material with normal cells may be the cause of the failure to 
detect any abnormalities in other 7 samples. We believe this study has provided the 
platform for further investigations to locate any tumor-suppressor genes and oncogenes 
in our NPC patients. 
International Joint Symposium Frontier in Biomedical Science: 
From Genes to Applications, November 24th and 25th, 2008 
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